These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8871642)
1. Kinetics of generation and persistence on membrane class II molecules of a viral peptide expressed on foreign and self proteins. Bot A; Bot S; Antohi S; Karjalainen K; Bona C J Immunol; 1996 Oct; 157(8):3436-42. PubMed ID: 8871642 [TBL] [Abstract][Full Text] [Related]
2. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin. Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850 [TBL] [Abstract][Full Text] [Related]
3. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040 [TBL] [Abstract][Full Text] [Related]
4. Viral peptide specific induction of MHC class II expression by murine T cell clones. Thomas DB; Smith CA; Graham CM J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637 [TBL] [Abstract][Full Text] [Related]
5. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance. Guéry JC; Sette A; Appella E; Adorini L J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867 [TBL] [Abstract][Full Text] [Related]
6. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation. Gombos I; Detre C; Vámosi G; Matkó J Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of monoclonal antibodies to a synthetic peptide of influenza haemagglutinin on the processing and presentation of viral antigens to class II-restricted T-cell clones. Mills KH Immunology; 1988 Nov; 65(3):365-71. PubMed ID: 2463222 [TBL] [Abstract][Full Text] [Related]
8. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera. Casares S; Stan AC; Bona CA; Brumeanu TD Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728 [TBL] [Abstract][Full Text] [Related]
9. Presentation of a viral peptide assembled on the carbohydrate moieties of immunoglobulin does not require processing. Brumeanu TD; Casares S; Dehazya P; Bot S; Bona CA Eur J Immunol; 1997 Sep; 27(9):2408-16. PubMed ID: 9341787 [TBL] [Abstract][Full Text] [Related]
10. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes. Eager KB; Hackett CJ; Gerhard WU; Bennink J; Eisenlohr LC; Yewdell J; Ricciardi RP J Immunol; 1989 Oct; 143(7):2328-35. PubMed ID: 2789261 [TBL] [Abstract][Full Text] [Related]
11. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells. Svensson M; Pfeifer J; Stockinger B; Wick MJ Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Harding CV; Unanue ER Nature; 1990 Aug; 346(6284):574-6. PubMed ID: 2115981 [TBL] [Abstract][Full Text] [Related]
13. Immunodominance does not result from peptide competition for MHC class II presentation. Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434 [TBL] [Abstract][Full Text] [Related]
14. Role of APC in the selection of immunodominant T cell epitopes. Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031 [TBL] [Abstract][Full Text] [Related]
15. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation. Hackett CJ; Yewdell JW; Bennink JR; Wysocka M J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146 [TBL] [Abstract][Full Text] [Related]
16. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes. Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280 [TBL] [Abstract][Full Text] [Related]
17. Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells. Eisenlohr LC; Gerhard W; Hackett CJ J Immunol; 1988 Oct; 141(8):2581-4. PubMed ID: 2459219 [TBL] [Abstract][Full Text] [Related]
18. MHC class II-transfected tumor cells directly present antigen to tumor-specific CD4+ T lymphocytes. Armstrong TD; Clements VK; Ostrand-Rosenberg S J Immunol; 1998 Jan; 160(2):661-6. PubMed ID: 9551900 [TBL] [Abstract][Full Text] [Related]
19. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972 [TBL] [Abstract][Full Text] [Related]
20. Presentation by recycling MHC class II molecules of an influenza hemagglutinin-derived epitope that is revealed in the early endosome by acidification. Sinnathamby G; Eisenlohr LC J Immunol; 2003 Apr; 170(7):3504-13. PubMed ID: 12646611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]